Fig. 2.
CD34+ cells sorted into CD13+and CD13− progenitor cells. (A) Presorted CD34+ cells. CD34+/c-kit+/CD13+cells averaged 10% to 15%. (B) Postsorted CD34+/c-kit+/CD13+cells. (C) Postsorted CD34+/c-kit+/CD13−cells. (D) Postsorted CD34+/c-kit−/CD13+cells. (E) Postsorted CD34+/c-kit−/CD13−cells. Similar results were obtained in 6 experiments separately performed, using either BM (n = 3) or PB (n = 3) cells in which the percentage of cells in quadrants of interest did not significantly differ between BM and PB.